ML Strategies Adds Food & Drug Administration Senior Policy Advisor Aaron Josephson to Washington, D.C. Office
September 20, 2018
December 17, 2018 | MedPage Today
This feature article looks at a recent federal court decision striking down the Affordable Care Act (ACA). The piece notes that while the decision will not immediately effect the ACA's implementation, there could be significant consequences down the road if the decision is ultimately upheld. ML Strategies Vice President Rodney Whitlock, a veteran health care policy advisor, is quoted in the piece.
December 12, 2018 | Medtech Insight
This feature story looks at a new revised bill focused on the Food & Drug Administration’s (FDA) regulation of diagnostics. The piece notes that the bill, currently being reviewed by members of Congress, would provide a great number of updates including the ability for FDA to leverage a pre-certification process to validate test developers. ML Strategies Senior Director Aaron Josephson is among the industry sources providing commentary in the piece.
December 10, 2018 | Roll Call
As health care costs continue to rise, this article looks at efforts being taken at the state and local levels targeting factors like housing, transportation, food and other nonmedical services as ways to overall improve the population's health while keeping medical costs down. ML Strategies Vice President Rodney Whitlock, a veteran health care policy advisor, is quoted in this article
The final word on the ACA's fate is years away, legal analysts say. But it could get messy in the meantime
December 2, 2018 | FierceHealthcare
This feature article notes that the future of the Affordable Care Act (ACA) remains uncertain for now in spite of the fact that a Texas District Court recently found that it is unconstitutional. Veteran health care policy advisor and ML Strategies Vice President Rodney Whitlock is among the industry sources quoted.
November 26, 2018 | Roll Call
ML Strategies Vice President Rodney Whitlock, a veteran health care policy advisor, is quoted in this article discussing the implications on prescription drug pricing as a result of Senator Chuck Grassley’s return to leading the Finance Committee.
November 20, 2018 | Inside Health Policy
ML Strategies Senior Director Aaron Josephson is among the industry sources providing commentary in this article on the FDA's proposal to test a minimally invasive dog drug study.